There are weeks on Wall Street when the tape is directionless and the biggest move comes from a single off-script comment from a minor official. And then there are weeks like this one, where the calendar is stacked and every major driver – monetary policy, corporate earnings, and economic momentum – is on the docket…
Published for the Treasury Select Committee
The shares of Vedanta Oil & Gas, Vedanta Iron & Steel, and Vedanta Power crashed up to 8% on Monday after the respective Q1 updates from the recently listed companies failed to impress Dalal Street bulls. Vedanta Aluminium Metal shares, however, gained over 1% on Monday morning. The four companies that were spun out of…
Italy’s securities regulator Consob has ordered the blocking of six additional websites found to be illegally offering investment services in financial instruments, according to a press release dated July 3, 2026. The blocked sites include “Mir-Partner” and its related domains, “Capital Trading Group” along with its associated page, “Gravmor” and its linked portals, White Mint…
What if the biggest thing standing between you and your financial goals isn’t your income, your debt, or the housing market — but your own brain? Dr. Julia Garcia is a psychologist, behavioral researcher, and author of The Five Habits of Hope — and she’s spent years studying why smart, hardworking people stay stuck. The…
Solstice to acquire Element Solutions for $14.5 billion
Its rankings-based model gave France a 24.5 percent chance of winning, against 31.5 percent in sportsbook odds and 34.1 percent in prediction markets, while Argentina drew 25.2 percent in the model but about 16 percent across both markets. In Canada, operators reported sharp increases in activity. BetMGM said bets placed per match in Canada rose…
Salesny was among the founders of Alpha Associates in 2004. Credit: Maks_lab/ Shutterstock.com. Amundi has named Petra Salesny as chief executive of Amundi Alpha Associates, the firm’s private markets multi-management business. The division manages more than €24bn under management across private equity, private debt, infrastructure and real estate. Access deeper industry intelligence Experience unmatched clarity with a single platform that…
Dr Douglas Williams is a veteran senior executive and board member for several biotech companies. During his time at Biogen, ZymoGenetics, Amgen Immunex and Seattle Genetics, he was involved in the development of several multibillion-dollar treatments, including Enbrel, Tecfidera and Spinraza. Matthew Partridge: The time and cost of clinical trials has been seen as one…
Are you a salaried employee? Have you ever taken a close look at your payslip to understand how your salary is structured? If not, now might be a good time. Recent developments around the Labour Codes and the Employees’ Provident Fund (EPF) rules have sparked widespread discussion. While one governs how your salary is structured,…